Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report.
atopic dermatitis
case report
dupilumab
psoriasis
Journal
Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
06
2023
accepted:
01
08
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Psoriasis and atopic dermatitis are relatively common in clinical practice, but it is rare for the two diseases to co-occur in the same patient. Dupilumab, an anti-IL-4/IL-13 monoclonal antibody, has been approved for treating moderate to severe AD. In addition to its therapeutic effects, dupilumab may induce new cutaneous adverse reactions. We report a rare case of pustular psoriasis induced during the treatment of atopic dermatitis with dupilumab. This case demonstrates the need for caution while treating patients with moderate to severe atopic dermatitis and staying vigilant for the emergence of new symptoms, especially with biological agents.
Identifiants
pubmed: 37601418
doi: 10.2147/CCID.S420904
pii: 420904
pmc: PMC10437099
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2217-2221Informations de copyright
© 2023 Liu et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Immunol Cell Biol. 2017 Oct;95(9):824-831
pubmed: 28649995
Clin Exp Dermatol. 2019 Apr;44(3):e49-e50
pubmed: 30656722
J Am Acad Dermatol. 2022 Mar;86(3):708-709
pubmed: 34022319
N Engl J Med. 2011 Aug 18;365(7):620-8
pubmed: 21848462
Br J Dermatol. 2021 Aug;185(2):432-434
pubmed: 33730377
Dermatitis. 2019 May/Jun;30(3):234-236
pubmed: 31094943
Curr Opin Immunol. 2017 Oct;48:68-73
pubmed: 28869867
Pharmaceuticals (Basel). 2022 Jul 17;15(7):
pubmed: 35890180
J Dermatolog Treat. 2021 Nov;32(7):716-720
pubmed: 31801394
Dermatol Ther. 2021 Nov;34(6):e15115
pubmed: 34455663
J Am Acad Dermatol. 2021 May;84(5):1339-1347
pubmed: 33428978
Dermatol Ther. 2022 Nov;35(11):e15851
pubmed: 36153663
Clin Exp Allergy. 2020 Jan;50(1):5-14
pubmed: 31505066
Hum Vaccin Immunother. 2019;15(9):2129-2139
pubmed: 30785362
Ital J Dermatol Venerol. 2022 Oct;157(5):449-450
pubmed: 36213969
J Am Acad Dermatol. 2020 Feb;82(2):430-439
pubmed: 31859047
Dermatol Ther. 2022 Nov;35(11):e15814
pubmed: 36088634
JAAD Case Rep. 2018 Aug 15;4(7):708-710
pubmed: 30128344
Dermatol Ther. 2021 Nov;34(6):e15117
pubmed: 34459079